JAMIE BUTLER: Open Payments
NPI 1508375114 · DOVER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 59 payments from 12 companies in 2025. Trend: 2023 $26 · 2024 $262 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $214 |
| ABBVIE INC. | 18 | $176 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Teva Pharmaceuticals USA, Inc. | 5 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Indivior Inc. | 2 | $37 |
| Braeburn Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: ARISTADA, VRAYLAR, REXULTI, UZEDY, CAPLYTA, SUBLOCADE, VIVITROL, BRIXADI.
Industry payments across OH — which companies pay providers there.
